Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00005035What this trial is testingOxaliplatin in Treating Patients With Advanced Head and Neck CancerWho this might be right forHead and Neck Cancer Ohio State University Comprehensive Cancer Center
Not applicableEnded earlyNCT00898430What this trial is testingBiomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 49
Not applicableStudy completedNCT00751816What this trial is testingHead & Neck Cancer Survivorship: Physical and Functional StatusWho this might be right forHead and Neck Cancer Vanderbilt University 23
Not applicableStudy completedNCT00963326What this trial is testingStudy of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerWho this might be right forHead and Neck Cancer Centre Oscar Lambret 30
Large-scale testing (Phase 3)Study completedNCT00003576What this trial is testingSurgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During SurgeryWho this might be right forHead and Neck Cancer National Cancer Centre, Singapore 200
Testing effectiveness (Phase 2)Study completedNCT00003582What this trial is testingRadiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerWho this might be right forCarcinoma of Unknown PrimaryHead and Neck Cancer University of Miami 36
Testing effectiveness (Phase 2)Looking for participantsNCT05136196What this trial is testingBiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more National Cancer Institute (NCI)
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Not applicableStudy completedNCT00899821What this trial is testingMicrosphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT01469429What this trial is testingPhase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.Who this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage 0 Hypopharyngeal Cancer+55 more Ohio State University Comprehensive Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT00492089What this trial is testingBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Meningioma+84 more National Cancer Institute (NCI) 11
Not applicableStudy completedNCT01314755What this trial is testingA Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck CancerWho this might be right forSquamous Cell Carcinoma of MouthSquamous Cell Carcinoma of OropharynxLaryngeal Squamous Cell Carcinoma+1 more Terrence Jones 76
Testing effectiveness (Phase 2)Study completedNCT00084318What this trial is testingAdjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and NeckWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 238
Testing effectiveness (Phase 2)Study completedNCT00019331What this trial is testingVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsWho this might be right forColorectal CancerEndometrial CancerHead and Neck Cancer+6 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Temporarily pausedNCT01810913What this trial is testingTesting Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerWho this might be right forOropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7+6 more National Cancer Institute (NCI) 613
Early research (Phase 1)Study completedNCT00030498What this trial is testingErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more National Cancer Institute (NCI) 75
Early research (Phase 1)Study completedNCT00003200What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and NeckWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 22
Testing effectiveness (Phase 2)Looking for participantsNCT02734537What this trial is testingRadiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryWho this might be right forHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+13 more ECOG-ACRIN Cancer Research Group 189
Testing effectiveness (Phase 2)Study completedNCT00101348What this trial is testingErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more National Cancer Institute (NCI) 66